Wastewater treatment expert: +86-181-0655-2851 Get Expert Consultation
Engineering Solutions

Pharmaceutical Wastewater Treatment in Uzbekistan (2026 Engineering Guide)

Pharmaceutical Wastewater Treatment in Uzbekistan (2026 Engineering Guide)

Why Pharmaceutical Effluent in Uzbekistan Demands a Dedicated Treatment Train

Pharmaceutical wastewater in Uzbekistan is treated using a multi-stage train — equalization, neutralization, DAF, MBR, and tertiary polishing — designed to meet the country's SanPiN sanitary norms and the State Committee for Ecology's maximum permissible concentrations. Influent COD typically ranges from 1,000 to 30,000 mg/L with a COD/BOD5 ratio of 1.5 to 4, so biological treatment alone is insufficient; a submerged MBR with PVDF membranes is the workhorse, delivering 80–90% removal of residual organics and APIs. Cold winters in Tashkent, Samarkand, and the Ferghana Valley require enclosed or buried bioreactors to keep mixed liquor above 10 °C.

Veolia's research across 50 pharmaceutical manufacturing plants puts influent COD between 400 and 62,000 mg/L, with one documented site at 300,000 mg/L — concentrations that no municipal or food-industry ETP in Uzbekistan is sized to handle (Veolia, 2020). Over 30 solvents are in routine use across API and finished-dose operations: ethanol, methanol, acetone, isopropanol, acetic acid, and glycols, with the low-boiling fraction (acetone, methanol, IPA) generating volatile organic loads that strip out of conventional activated-sludge basins. Detergents from equipment and floor cleaning drive foaming events that destabilize clarifiers. Adding to that, an estimated 30–75% of hospital-linked effluent contains active pharmaceutical ingredients, a relevant benchmark as Uzbekistan expands its domestic finished-dose capacity around the Tashkent Pharma Park and the Ferghana Valley industrial zones (Baker et al. 2021, cited via Water & Wastewater, 2026).

Two Uzbekistan-specific constraints make a generic pharma skid fail. First, ambient temperatures swing from -5 °C in January to +45 °C in July; open bioreactors lose 6–8 °C of mixed liquor in Tashkent winters, which collapses nitrification below 10 °C. Second, grid power in newly developed industrial parks is unstable, with documented 2–4 h outages that crash biomass when blowers and pumps are not on VFDs with adequate turndown. Engineers designing for these sites must integrate SanPiN discharge compliance, PDV permit ceilings, cold-climate tankage, and low-kW rotating equipment into a single train from day one. The Tashkent hospital wastewater treatment guide applies similar logic to a related effluent class.

Uzbek Pharmaceutical Effluent: Regulatory Limits and Discharge Targets

SanPiN 0173-21 sanitary-chemical MPCs and the State Committee for Ecology's PDV (predelno dopustimyy vybros) permit ceilings together define the compliance envelope that the ETP must hit on a daily and composite basis. The two frameworks are not redundant: SanPiN governs sanitary-chemical and microbiological quality of the receiving water body, while PDV caps the concentration and mass load that can be discharged to municipal sewer or surface water under an integrated permit.

For surface-water discharge to fishery-sensitive bodies, SanPiN MPCs typically require BOD5 ≤ 3 mg/L, COD ≤ 30 mg/L (after accounting for background dilution), suspended solids ≤ 10 mg/L, and residual chlorine below 0.01 mg/L. For municipal sewer discharge under a PDV permit, the State Committee for Ecology commonly enforces COD ≤ 500 mg/L, TSS ≤ 100 mg/L, pH 6.5–8.5, oil & grease ≤ 10 mg/L, ammonium-N ≤ 15 mg/L, sulfates ≤ 300 mg/L, and chlorides ≤ 300 mg/L — the last two parameters become binding on API plants using sulfate- and chloride-based salt trains. Antibiotic residue and total residual API activity (measured by Daphnia or bioluminescence toxicity) are increasingly enforced on Uzbek pharma parks; these are the parameters that push designers toward tertiary polishing rather than relying on a biological stage alone.

ParameterSanPiN surface-water MPC (fishery)State Committee PDV (municipal sewer)Typical pharma plant influent (Veolia, 2020)
COD (mg/L)≤ 30≤ 500400 – 62,000
BOD5 (mg/L)≤ 3≤ 350200 – 25,000
TSS (mg/L)≤ 10≤ 100100 – 5,000
pH6.5 – 8.56.5 – 8.52 – 12 (batch swings)
Oil & grease (mg/L)≤ 0.05≤ 1050 – 500
Ammonium-N (mg/L)≤ 0.5≤ 1520 – 200
Sulfates (mg/L)≤ 100≤ 300200 – 3,000
Chlorides (mg/L)≤ 300≤ 300500 – 10,000
Toxicity to DaphniaNon-toxic at 10× dilutionPer permitFrequently toxic untreated

The gap between column three and columns one/two is the 2–3 log reduction that the engineered train has to deliver. Skipping the equalization step, undersizing the MBR, or omitting tertiary polishing makes compliance impossible against these limits.

Characterizing the Influent: COD, BOD, Solvents, and Salinity

Characterizing the Influent: COD, BOD, Solvents, and Salinity

A defensible basis-of-design for an Uzbek API or finished-dose plant typically starts from the following envelope: COD 1,000 – 30,000 mg/L, BOD5 300 – 8,000 mg/L, COD/BOD5 1.5 – 4, TSS 200 – 1,500 mg/L, total nitrogen 50 – 300 mg/L, chloride 500 – 5,000 mg/L (driven by API salt use and CIP), sulfate 200 – 3,000 mg/L, and oil & grease 50 – 500 mg/L. The 30+ solvents documented by Veolia (ethanol, methanol, acetone, isopropanol, acetic acid, glycols) appear as COD but with widely varying volatility and biodegradability, and the volatile low-boiling fraction must be stripped or stripped-and-condensed before the biological stage to avoid defouling membranes and stripping the dissolved oxygen.

Per Veolia's biodegradability framework, a COD/BOD5 ratio above 3 signals an effluent that is poorly biodegradable, which pushes the train away from activated sludge alone and toward an MBR with downstream advanced oxidation (Veolia, 2020). Salinity is the second design driver: chloride above 1,000 mg/L corrodes standard 304 stainless, so the MBR frame, piping, DAF contact chamber, and chemical dosing tanks should be specified in 316L stainless, FRP, or UPVC. Bench-scale testing should include 24-hour composite sampling across at least three production batches, plus jar tests for coagulant selection (typically PAC at 50 – 150 mg/L paired with anionic polyacrylamide at 1 – 3 mg/L). A PLC-controlled coagulant and pH dosing skid sized for 7-day reagent storage is the practical way to convert those jar-test results into repeatable full-scale operation.

ParameterTypical Uzbek API/finished-dose rangeDesign implication
COD1,000 – 30,000 mg/LHigh-strength; needs MBR + tertiary
BOD5300 – 8,000 mg/LBiological stage viable if ratio ≤ 3
COD/BOD51.5 – 4Ratio > 3 → add AOP or GAC
TSS200 – 1,500 mg/LDAF primary separation required
Total nitrogen50 – 300 mg/LNitrification needed; cold-protected
Chloride500 – 5,000 mg/L316L/FRP/UPVC materials
Temperature15 – 40 °CCooling + winter insulation

The Recommended Process Train: Equalization → DAF → MBR → Polishing

The defensible train for an Uzbek API/finished-dose plant is a five-unit sequence: equalization → neutralization → coagulation/DAF → MBR → tertiary polishing, followed by disinfection. Each unit is non-negotiable for the conditions on the ground.

Equalization basin. 8 – 12 h HRT with mechanical mixing and air-bubble stripping for low-boiling solvents (acetone, methanol, IPA). This dampens the batch swings in COD, pH, and flow that Veolia's 50-plant dataset shows are characteristic of API production. Stripping the volatile fraction here also protects the downstream MBR from defouling events.

Neutralization stage. PLC-controlled acid/base dosing tied to inline pH meters, targeting pH 6.5 – 7.5 before biological treatment. The PLC-controlled coagulant and pH dosing skid handles both pH correction and coagulant feed for the DAF.

Coagulation + DAF. Polyaluminum chloride (PAC) at 50 – 150 mg/L plus anionic polyacrylamide at 1 – 3 mg/L, hydraulic residence 20 – 30 min, air-to-solid ratio 0.005 – 0.015. This is the configuration used in Veolia's Treatment Lines A and F, where DAF follows biological carriers for FOG, surfactant, and colloidal solids removal. A DAF system for pharmaceutical pre-treatment sized to peak batch flow is the standard answer.

Biological stage. Choose between MBBR (carriers 30 – 50% fill) and submerged MBR. For Uzbek sites, MBR is preferred because the higher MLSS (6,000 – 10,000 mg/L) buffers against cold-weather nitrification collapse and against toxic shocks from batch releases. A submerged MBR system with aerobic HRT 18 – 30 h, design mixed-liquor temperature ≥ 12 °C, and a DF series PVDF flat-sheet membrane module at 0.1 – 0.4 µm pore size and design flux 12 – 18 L/m²·h (peak ≤ 25 L/m²·h) delivers 80 – 90% removal of bulk organics and APIs (Zhao et al. 2014). Intermittent backwash and chemical CIP every 30 – 60 days keep transmembrane pressure within target.

Tertiary polishing. GAC or AOPs (Fenton or O3/H2O2) for refractory COD and residual API traces. GAC achieves 70% removal on a broad API mix (Huang et al. 2018); Fenton and O3/H2O2 exceed 90% on specific APIs such as diclofenac and ibuprofen (Yuan et al. 2019). For sites with tight SanPiN residual-API or toxicity limits, AOPs are not optional.

Disinfection. An on-site ClO2 generator sized for 0.5 – 1.5 mg/L residual is preferred over chlorine gas for pharma effluent because chlorine dioxide is less reactive with ammonia and produces fewer regulated DBPs.

UnitDesign parameterUzbek-specific value
EqualizationHRT, mixing, stripping8 – 12 h, mechanical + air bubble
NeutralizationpH target6.5 – 7.5, PLC-controlled
DAFHRT, air-to-solid20 – 30 min, A/S 0.005 – 0.015
MBRHRT, MLSS, flux18 – 30 h, 6,000 – 10,000 mg/L, 12 – 18 L/m²·h
AOP / GACRemoval on APIs70% (GAC) – 90%+ (AOP)
ClO2 disinfectionResidual0.5 – 1.5 mg/L

Cold-Climate and Power-Stability Design Adjustments for Uzbekistan

Cold-Climate and Power-Stability Design Adjustments for Uzbekistan

Generic MBBR/MBR parameters assume a temperate climate and a stable grid. Uzbekistan requires specific adjustments. The single most common cause of winter underperformance in Uzbek pharma ETPs is mixed liquor dropping below 10 °C, which collapses nitrification and pushes ammonium-N above the 15 mg/L PDV ceiling. The fix is straightforward in principle but must be specified at the design stage: below-grade or insulated equalization and aerobic tankage, with a documented mixed-liquor temperature ≥ 12 °C at design winter ambient. Above-grade tanks in Tashkent commonly lose 6 – 8 °C in January, which is enough to crash nitrification on a borderline design.

Grid stability is the second design driver. Documented 2 – 4 h power outages in newly developed industrial parks around Tashkent and the Ferghana Valley are enough to wash out biomass if blowers and pumps do not have variable-frequency drives with adequate turndown. The defensible specification is blowers and recirculation pumps on VFDs sized at 1.3 – 1.5× turndown, dual blower train with each unit capable of carrying 70% of design air demand, and a control philosophy that treats a power event as a recoverable transient rather than a process shutdown. For high-salinity sites (e.g., chloramphenicol or NaCl-heavy API lines), drop MLSS to 4,000 – 6,000 mg/L and increase aeration to maintain DO at 2 – 3 mg/L; high chlorides inhibit nitrifiers, and the standard 8,000 mg/L MLSS envelope will not hold.

Equipment Selection: What to Specify When Sourcing from China

The procurement-ready shortlist below maps each process unit to a specific equipment spec that a Chinese supplier can quote against. The dominant cost drivers — DAF contact chamber, MBR membrane area, chemical skid, sludge dewatering — are the four line items that drive CAPEX on a 50 – 500 m³/d Uzbek pharma ETP.

  • DAF system: 4 – 50 m³/h capacity, skid-mounted, stainless or FRP contact chamber, micro-bubble saturation tank 30 – 60 s retention. A DAF system for pharmaceutical pre-treatment with a documented air-to-solid ratio test certificate is the standard ask.
  • MBR skid: 10 – 500 m³/d, submerged PVDF flat-sheet or hollow-fiber, factory-tested with a 72-h wet trial before shipment, and a documented membrane cleaning protocol tied to TMP triggers. The integrated MBR system and DF series PVDF flat-sheet membrane module cover the standard size range.
  • Chemical dosing: PLC-controlled, skid-mounted, PE/PP chemical tanks sized for 7-day on-site storage — important for remote Uzbek industrial sites where reagent delivery is slow. A PLC-controlled coagulant and pH dosing skid with PE tanks and a calibration record is the minimum.
  • Chlorine dioxide generator: matched to peak flow, factory acceptance test for ClO2 yield, and a local reagent supply plan. The on-site ClO2 generator covers 0.5 – 1.5 mg/L residual capacity at peak flow.
  • Plate-and-frame filter press: 5 – 30 m² filter area for the sludge line, since most Uzbek pharma plants must dewater to 25 – 35% DS before offsite sludge disposal. The plate-and-frame filter press for sludge dewatering covers the standard footprint.
EquipmentCapacity rangeKey spec to verifyMaterial
DAF4 – 50 m³/hA/S ratio test certificateSS304 / FRP
MBR skid10 – 500 m³/d72-h wet trial, CIP protocolSS316L / UPVC piping
Membrane module0.1 – 0.4 µm PVDFFlux 12 – 18 L/m²·h designPVDF, ABS frame
Chemical dosing7-day tank storagePLC calibration recordPE / PP tanks
ClO2 generator0.5 – 1.5 mg/L residualClO2 yield FAT certificateUPVC / PVDF reactor
Filter press5 – 30 m²Cake DS ≥ 25%PP plates, SS frame

CAPEX is dominated by membrane area, stainless/FRP tankage, and the AOP skid if SanPiN residual-API limits are tight. OPEX is dominated by aeration energy (blower kWh is typically 40 – 60% of total electrical load on an MBR-based plant), membrane replacement (PVDF modules typically 5 – 7 year life), and chemical consumption (PAC, polyacrylamide, NaOH/H2SO4, ClO2 reagent). Two supplier-evaluation questions that procurement can put in front of any short-listed Chinese vendor: (1) "Provide a 72-h wet-test certificate and a documented CIP protocol for the MBR membrane modules you are quoting." (2) "Provide a documented mixed-liquor temperature case study for a winter ambient of -5 °C, including tankage detail and blower turndown philosophy." A vendor that cannot answer both is not yet qualified for an Uzbek pharma ETP.

Frequently Asked Questions

What influent COD can a submerged MBR handle on a typical Uzbek API plant?

Submerged MBRs with PVDF flat-sheet or hollow-fiber membranes at 0.1 – 0.4 µm routinely handle 8,000 – 12,000 mg/L COD with 80 – 90% removal efficiency. For COD above 15,000 mg/L, the train typically adds an anaerobic stage upstream or dilutes via a larger equalization basin to keep the membrane flux at the design 12 – 18 L/m²·h range.

How cold can the mixed liquor get before nitrification fails in Uzbekistan?

Nitrification rate drops sharply below 10 °C and effectively halts around 5 °C. The defensible design target for an Uzbek winter is mixed liquor ≥ 12 °C, achieved through below-grade or insulated tankage. Above-grade tanks in Tashkent lose 6 – 8 °C in January, which is enough to push ammonium-N above the 15 mg/L PDV ceiling on a borderline design.

Why is DAF placed before the MBR rather than after?

DAF removes FOG, surfactants, and colloidal solids upstream of the membrane, which is critical for pharma effluent where detergents and excipients cause foaming and defouling. Placing DAF before the MBR keeps the MLSS more stable, reduces CIP frequency from every 14 – 21 days to every 30 – 60 days, and protects the membrane surface from oil-coated fouling that is hard to remove chemically.

What is the typical CAPEX split for a 100 m³/d Uzbek pharma ETP?

For a 100 m³/d greenfield plant, tankage and civil works typically absorb 30 – 35% of CAPEX, the MBR skid with membranes 25 – 30%, the DAF and chemical dosing 10 – 15%, the AOP or GAC tertiary skid 10 – 15% (if included for residual-API limits), and the sludge dewatering press plus disinfection generator the remaining 10 – 15%. Imported equipment from China typically carries 5 – 15% customs duty plus VAT, which is why pre-engineered skidded systems with consolidated shipping beat loose equipment for remote Uzbek sites.

Further Reading

References

  1. Carbon Electrodes for Pharmaceutical Wastewater Treatment
  2. What is Pinch Valve: Types, Working Principle, Pros & Cons
  3. PHARMACEUTICAL MANUFACTURING - Veolia Water Tech
  4. Introduction: Occurrences, sources, and methods of pharmaceutical wastewater treatment
  5. Pharmaceutical Wastewater Treatment - Water & Wastewater

Related Articles

Pharmaceutical Wastewater Treatment in Rwanda (2026 Engineering Guide)
Aug 25, 2026

Pharmaceutical Wastewater Treatment in Rwanda (2026 Engineering Guide)

Pharmaceutical wastewater treatment in Rwanda: 2026 REMA process, COD limits, and equipment train f…

Contact
Contact Us
Call Us
+86-181-0655-2851
Email Us Get a Quote Contact Us